Condition:   Cytomegalovirus Infection
Interventions:   Biological: Adoptive Cellular Therapy;   Drug: Best available antiviral drug therapy
Sponsors:   Cell Medica Ltd;   Wellcome Trust;   Choice Pharma Ltd;   Commitum AB;   BioAnaLab
Recruiting - verified February 2010

Condition:   Coronary Artery Disease
Intervention:   Device: Radi pressure wire (pressure wire assessment)
Sponsor:   Southampton University Hospitals NHS Trust
Recruiting - verified October 2009

Conditions:   Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu Arteritis
Intervention:  
Sponsors:   University of Oxford;   American College of Rheumatology;   The European League Against Rheumatism (EULAR);   The Vasculitis foundation
Not yet recruiting - verified February 2010

Condition:   Type 1 Diabetes Mellitus
Interventions:   Biological: otelixizumab;   Biological: placebo
Sponsors:   Tolerx Inc.;   Juvenile Diabetes Research Foundation
Active, not recruiting - verified March 2009

Conditions:   Lymphoma;   Neutropenia;   Psychosocial Effects of Cancer and Its Treatment;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions:   Drug: amoxicillin-clavulanate potassium;   Drug: ciprofloxacin;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
Sponsor:   Clatterbridge Centre for Oncology
Recruiting - verified May 2007

Conditions:   Fabry Disease;   Cerebrovascular Accident
Intervention:   Other: No intervention
Sponsors:   University of Rostock;   Shire Human Genetic Therapies, Inc.
Recruiting - verified February 2010

Condition:   Cerebrovascular Accident
Intervention:   Other: No intervention
Sponsors:   University of Rostock;   Shire Human Genetic Therapies, Inc.
Completed - verified February 2010

Conditions:   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer
Interventions:   Drug: capecitabine;   Other: clinical observation;   Procedure: adjuvant therapy
Sponsor:   Southampton University Hospitals NHS Trust
Recruiting - verified March 2008

Conditions:   Arthritis, Rheumatoid;   Osteoarthritis
Interventions:   Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
Sponsors:   Pfizer;   The Cleveland Clinic
Recruiting - verified March 2010

Condition:   Sarcoma
Interventions:   Biological: dactinomycin;   Drug: busulfan;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: conventional surgery;   Radiation: radiation therapy
Sponsors:   University Hospitals, Leicester;   National Cancer Institute (NCI);   Children's Cancer and Leukaemia Group;   Societe Francaise Oncologie Pediatrique;   European Organization for Research and Treatment of Cancer;   Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany;   Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria;   Swiss Group for Clinical Cancer Research;   EBMT Solid Tumors Working Party;   Children's Oncology Group
Recruiting - verified March 2010

Condition:   Leukemia
Interventions:   Drug: asparaginase;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisolone;   Drug: prednisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Procedure: allogeneic bone marrow transplantation
Sponsor:   Dutch Childhood Oncology Group
Active, not recruiting - verified October 2006

Condition:   Prostate Cancer
Interventions:   Biological: luteinizing hormone-releasing factor;   Radiation: radiation therapy
Sponsor:   Medical Research Council
Active, not recruiting - verified July 2001